Evidence map›Paper›PMID 35736493›Full record

ArticleMetabolites2022

UHPLC-MS Metabolomic Fingerprinting, Antioxidant, and Enzyme Inhibition Activities of

Carlos Areche, Javier Romero Parra, Beatriz Sepulveda, Olimpo García-Beltrán, Mario J Simirgiotis

Abstract read
In one paragraph

Article in Metabolites, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Identification of Secondary Metabolites from the LichenMolecules (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Biological activities ofFrontiers in pharmacology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carlos ArecheDepartamento de Química, Facultad de Ciencias, Universidad de Chile, Las Palmeras 3425, Nuñoa, Santiago 7800024, Chile.ORCID 0000-0001-5246-1368
Javier Romero ParraDepartamento de Química Orgánica y Fisicoquímica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Olivos 1007, Casilla, Santiago 6640022, Chile.
Beatriz SepulvedaDepartamento de Ciencias Químicas, Viña del Mar, Universidad Andres Bello, Viña del Mar 2520000, Chile.
Olimpo García-BeltránFacultad de Ciencias Naturales y Matemáticas, Universidad de Ibagué, Carrera 22 Calle 67, Ibagué 730001, Colombia.ORCID 0000-0003-3312-1776
Mario J SimirgiotisInstituto de Farmacia, Facultad de Ciencias, Universidad Austral de Chile, Elena Haverbeck S-N, Valdivia 5090000, Chile.

Funding

instituto antartico chileno rt 16-17
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlzheimerAntarcticaantioxidantdepsidesdibenzofuransenzyme inhibitionHimantormianative lichensphenolics

Identifiers

PMID35736493
PMCPMC9227586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.